Navigation Links
Biozoom Exercises Purchase Option Under Joint Venture Agreement With Spectroscopic Technology Developer, Opsolution
Date:6/14/2013

AGOURA HILLS, Calif., June 14, 2013 /PRNewswire/ -- Biozoom (OTC QB: BIZM) exercised its option, under a joint venture agreement, to acquire 19.9% of Opsolution, a research and development company dedicated to advancing spectroscopic technology.  Pursuant to the joint venture between the two companies, Opsolution assigned to Biozoom all of its rights to Opsolution's future intellectual property, whether developed or acquired, including licenses and royalty rights. In exchange, Biozoom agreed to fund Opsolution's ongoing research and development activities by matching certain grant funds awarded to Opsolution by the German government.  Under Biozoom's asset purchase agreement with Opsolution, executed in parallel with the joint venture, Biozoom acquired all of Opsolution's existing tangible and non-tangible assets.

"Both companies can concentrate on what they do best," said Hardy Hoheisel, CEO of Biozoom. "Opsolution can focus on the R & D, while Biozoom aggressively pursues large-scale sales opportunities and relationships with distribution partners in the health and wellness industry."

The joint venture agreement gives Biozoom access to intellectual property and patents as they are developed and acquired. "Opsolution is conducting the research that we hope will enable our next generation Biozoom scanner to measure common medical values, including cholesterol and blood sugar levels. We believe this will lead to wide adoption by the healthcare community when the new scanner is perfected," said Hoheisel.

Opsolution developed the ground-breaking technology to miniaturize laboratory-quality spectroscopy, enabling the creation of Biozoom's mobile handheld device. This miniaturization was based on collaboration with one of the world's leading optical engineering companies, Carl Zeiss. This optics technology is at the heart of the current scanner, the
'/>"/>

SOURCE Biozoom
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Biozoom Launches Sales & Business Development Office In Strategic Southern California Location
2. Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
3. Array BioPharma Announces Exercise Of Underwriters Option To Purchase An Additional $17.25 Million Of 3.00% Convertible Senior Notes
4. Isis Pharmaceuticals Announces Exercise of Underwriters Option to Purchase Additional Shares
5. Vasomedical Announces Share Repurchase Program of up to $1.5 Million in Common Stock
6. Precision Optics Corporation Announces Reciept Of $660,000 Purchase Order For Custom-Designed Endoscopes
7. PAREXEL International Provides Update On Share Repurchase Program, Announces A New $50 Million Accelerated Share Repurchase Agreement And A New $50 Million 10b5-1 Trading Plan
8. WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2012 Results, Share Repurchase Program
9. Roswell Park Cancer Institute Purchases Six Ion Torrent Sequencers
10. BioMed Realty Trust Announces Exercise Of Option To Purchase Additional Shares Of Common Stock
11. xG Technology Receives $2,500,000 Purchase Commitment for xMax Broadband Network Equipment from Telemedicine-MM Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... , Oct. 22, 2014  AcelRx Pharmaceuticals, ... that results from the  IAP310 study have been ... (RAPM), a peer-reviewed journal with broad, multidisciplinary ... trial evaluating the safety and efficacy of Zalviso, ... system (SSTS), for the treatment of post-operative pain ...
(Date:10/22/2014)... , Oct. 22, 2014   Foundation ... WuXi PharmaTech (Cayman) Inc. (NYSE: WX ) ... genomic profiling to biopharmaceutical companies conducting clinical trials in ... the terms of the collaboration, Foundation Medicine will license ... Foundation Medicine,s FoundationOne® assay at the WuXi Genome Center ...
(Date:10/20/2014)... , Oct. 20, 2014  Indianapolis interventional medical ... Toronto -based 3D visualization leader ... of Neurological Surgeons Annual Meeting that they have ... brain surgery. The collaboration is the first of ... to improve patient outcomes. NICO,s BrainPath® interventional access ...
Breaking Medicine Technology:AcelRx Announces Publication of Zalviso Phase 3 Abdominal Trial Results 2Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 2Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 3Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 4Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 5Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 2Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 3Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 4Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 5
... 14, 2012 Ingenol mebutate was proven efficacious ... Today, the New England Journal of Medicine (NEJM) ... Phase III clinical trials for ingenol mebutate gel, demonstrating that ... of actinic keratoses (AKs) on the trunk-extremities or face-scalp with ...
... DIEGO, March 14, 2012 Arena Pharmaceuticals, Inc. (NASDAQ: ... the fourth quarter and full year ended December 31, ... the potential to be an important option for physicians ... lose weight and improve their overall cardiometabolic health," said ...
Cached Medicine Technology:New England Journal of Medicine Article Reviews the Benefits of Ingenol Mebutate in Field Treatment of Actinic Keratoses 2New England Journal of Medicine Article Reviews the Benefits of Ingenol Mebutate in Field Treatment of Actinic Keratoses 3New England Journal of Medicine Article Reviews the Benefits of Ingenol Mebutate in Field Treatment of Actinic Keratoses 4New England Journal of Medicine Article Reviews the Benefits of Ingenol Mebutate in Field Treatment of Actinic Keratoses 5Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Financial Results and Reviews Recent Developments 2Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Financial Results and Reviews Recent Developments 3Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Financial Results and Reviews Recent Developments 4Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Financial Results and Reviews Recent Developments 5Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Financial Results and Reviews Recent Developments 6Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Financial Results and Reviews Recent Developments 7Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Financial Results and Reviews Recent Developments 8
(Date:10/22/2014)... TX (PRWEB) October 22, 2014 On ... Criminal Minds featuring skin diseases both fictional and ... (CEHMDF), a nonprofit organization committed to advocacy and ... if CBS will take the opportunity to impart truth ... , There are many misconceptions about ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 Isabel ... of Allied Health Professions (ASAHP) Conference on October 22-24 ... CEO will participate in a panel discussion on Technology ... , Isabel Healthcare provides a diagnostic decision support tool ... the diagnosis skills of students and clinical learners. The ...
(Date:10/22/2014)... Amy Norton HealthDay Reporter , ... on the three Ebola cases in Dallas. But, mental health ... to Americans. President Barack Obama on Friday appointed an ... which has infected two Dallas nurses who cared for a ... Health Presbyterian Hospital. But the U.S. cases are miniscule ...
(Date:10/22/2014)... October 22, 2014 Shriners Hospitals for ... will change the current location of Shriners Hospitals for ... Limestone across from the University of Kentucky Albert B. ... ambulatory care center, owned and operated by Shriners Hospitals ... needs of children and their families well into the ...
(Date:10/22/2014)... October 22, 2014 Hay House is pleased ... Addiction and Upgrade Your Life (Paperback; $10.82) written by the ... & Recovery. This book is meant to help readers ... life of recovery. , Recovery 2.0 is not the ... Recovery 2.0 is a guide for what comes next. ...
Breaking Medicine News(10 mins):Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 3Health News:Isabel Healthcare to Participate in The Association of Schools of Allied Health Professions (ASAHP) 2014 Conference 2Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 2Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 3Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 2Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 3Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 2Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 3
... ... of award-winning natural skin and hair care products for children, is reminding ... rays and potential toxins found in many sunscreens. TruKid has always ... dioxane, BPA and paraben free, offering excellent UVA/UVB protection SPF. We ...
... ... of Medical Genetics to meet virtual repository technology needs of the network, , ... Reston, VA (PRWEB) June ... the American College of Medical Genetics (ACMG) has selected the company to contribute web-based ...
... ... Ferro achieved explosive sales growth of 427 percent between 2007 - 2009 to qualify for ... described as a “win/win/win for all involved.” , ... Marlton, NJ (PRWEB) June 15, 2010 -- Amid all the ...
... ... must be eliminated to stop the terrible human suffering and environmental toll exacted through ... difference. , ... June 15, 2010 -- Adrian Desbarats, owner of an organic clothing company ...
... OAK BROOK, Ill. A new study suggests that computed ... of having pulmonary embolism (PE), based on the results of ... exposure and costs associated with CT angiography. The results of ... issue of the journal Radiology . ...
... could prevent 100,000 deaths worldwide each year, study suggests ... drug commonly used to prevent excess bleeding in surgeries ... after trauma, a new study suggests. , The drug, ... world and easily administered, experts said. It works by ...
Cached Medicine News:Health News:TruKid, the Award-Winning Line of Natural Products for Children, Wants to Help Keep your Kids Safe in the Sandbox this Summer 2Health News:TruKid, the Award-Winning Line of Natural Products for Children, Wants to Help Keep your Kids Safe in the Sandbox this Summer 3Health News:Technology Innovation Advances Newborn Screen Translational Research Network 2Health News:Technology Innovation Advances Newborn Screen Translational Research Network 3Health News:Free For All Honored for Explosive Growth, 2007 – 2009 2Health News:Free For All Honored for Explosive Growth, 2007 – 2009 3Health News:Organic Clothing – Is Your Clothing Delivering Death in Small Doses? 2Health News:Organic Clothing – Is Your Clothing Delivering Death in Small Doses? 3Health News:CT angiography may be unnecessary in patients with suspected pulmonary embolism 2Health News:Drug That Stops Bleeding Could Save Lives 2Health News:Drug That Stops Bleeding Could Save Lives 3
... flexible Mediprene® material, Available in even sizes ... nasal airway maximizing patient comfort. The Latex-Free ... patient comfort while offering the best solution ... allowing you to offer a quality latex-free ...
Soft PVC. Available in sizes 12-36F, Interior striations for smooth suction catheter insertion. Bevel tip. Single use. Sterile....
Color Coded Guedel Oral Airways are individually bagged, latex free, and color Coded for size identification....
Flexible vinyl with a rigid bite block. Guedel-style with three internal channels. Individually packaged, 48 per case. Latex Free....
Medicine Products: